HINJ Comment Submission for Section 232 Investigation on Pharmaceutical Tariffs
Trenton, May 12, 2025 ― HINJ submitted comments to the Department of Commerce as per the Federal Register’s Notice of Request for Public Comments on
Trenton, May 12, 2025 ― HINJ submitted comments to the Department of Commerce as per the Federal Register’s Notice of Request for Public Comments on
Trenton, April 23, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ), released the following statement concerning
by Chrissy Buteas, President and Chief Executive OfficerHealthCare Institute of New Jersey (HINJ) America is a kaleidoscope of incredible cities and states, each with its
Trenton, January 21, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning comments
Trenton, January 17, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning the
Trenton, January 15, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning yesterday’s
Steve Issenman
Senior V.P.
732-729-9621
issenman@hinj.org
HealthCare Institute of New Jersey (HINJ)
10 W. Lafayette Street
Trenton, NJ 08608
Phone: 732-729-9619
©2025. HealthCare Institute of New Jersey (HINJ). All rights reserved.